Yesterday at INTERPHEX, attendees had the opportunity to meet representatives from the category winners of the Facility of the Year Awards (FOYA) at a reception. The awards program, now in its fifth year, recognizes companies that advance pharmaceutical manufacturing technology. Read more »
Last week’s post highlighted pharma deals that haven’t been working out due to rejected bids and stalled negotiations. On a more positive note, the past several months have also seen some successful acquisitions. This past week produced updates to some of Big Pharma’s pending pacts. Read more »
“The Physician Payments Sunshine Act” (see my previous post), introduced by Senators Chuck Grassley (R-IA) and Herb Kohl (D-WI), would require drug companies to disclose their payments to physicians. Besides showing how the pharmaceutical industry can influence the way doctors practice medicine, the act would also illustrate how industry payments might influence university research about drugs. Read more »
From PharmTech.com